Watson and Arrow, a leading global specialty
pharmaceutical company

As a result of the recent completion of our acquisition of the Arrow Group, Watson now has operations in many of the world's most established and growing international markets.

The acquisition creates a global pharmaceutical company with over $3 billion in revenue. It marks a significant milestone for Watson in realizing our strategic vision to expand our global footprint and leverage our assets across many developed and emerging markets around the world. The combined company has a global infrastructure and a strong product portfolio and pipeline; creating significant opportunities for long-term growth. Additionally, Arrow's strong manufacturing network, including facilities in Brazil, Canada and Malta, will further expand Watson's global supply chain.

Watson and Arrow Combined Company Map

Corona, CA, USA
Corporate Headquarters

Morristown, NJ, USA
Commercial Headquarters, Executive Offices

Toronto, CANADA
R&D/Manufacturing

Coleraine, IRELAND

Melbourne, AUSTRALIA
Research & Development

Goa, INDIA
Manufacturing

Mumbai, INDIA

Rio de Janeiro, BRAZIL
Manufacturing

MALTA
Manufacturing

Changzhou, CHINA

Davie, FL, USA
R&D/Manufacturing

	Headquarters Corona, CA – Corporate Headquarters Morristown, NJ – Executive Offices, Commercial Headquarters		Current Selling/Marketing Operations Australia, Brazil, Canada, Central and Eastern Europe, China, France, Germany, Malta, New Zealand, Scandinavia, South Africa, United Kingdom, United States
	API, Distribution, R&D, Manufacturing U.S. – Carmel, NY; Corona, CA; Copiague, NY; Davie, FL; Grand Island, NY; Gurnee, IL; Groveport, OH; Salt Lake City, UT; Weston, FL International – Australia; Brazil; Canada; Changzhou, China; Coleraine, Ireland; Goa, India; Mumbai, India; Malta		Product Applications/Approvals Austria, Belgium, Cyprus, Czech Republic, Finland, Hungary, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Portugal, Slovakia, Spain, Switzerland, Turkey